Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Awareness of rabies prevention and control is driving significant trends and advances in the rabies diagnostics industry. This industry must diagnose and manage the deadly virus, hence effective and efficient diagnostic tools are needed.
The market is driven by rising global rabies rates. Rabies incidence are rising, particularly in developing countries, highlighting the need for precise and fast diagnoses to control the illness.
Rapid and precise rabies testing are achievable due to technology. Since PCR and nucleic acid amplification are more precise and quicker than previous procedures, they are becoming more popular.
Rabies veterinary diagnostics are in high demand, boosting the sector. Rabies may be carried from animals to humans, thus early diagnosis is crucial to protecting animals and people. Cattle may get rabies from animals.
Point-of-care tests provide fast diagnosis without sophisticated laboratory equipment, making them increasingly popular. This propensity is crucial for timely intervention and management in remote areas where centralized laboratories may be unavailable.
Alarmingly, diagnostic firms, research institutions, and government organizations are collaborating more. These collaborations will boost research and development, leading to more efficient and accessible rabies diagnostic technology.
Rabies control is becoming increasingly important to governments worldwide, resulting in higher investment on diagnostic facilities and awareness programs. Combining these actions with vaccine programs creates a comprehensive viral prevention approach.
Rabies is common in emerging countries, where the market is expanding to reach more individuals. Growth is enabled by strategic market players targeting these places to satisfy unmet diagnostic needs and improve sickness management.
Serological testing for rabies is becoming increasingly widespread, especially for post-exposure prophylactic surveillance. These tests help determine vaccination efficacy and guide medical treatment by revealing the immune response.
Rabies diagnostic kit licensing and marketing are heavily regulated, which affects the market. Compliance with these principles builds confidence in healthcare professionals and patients by making diagnostic equipment safe and effective.
Rabies diagnostics is consolidating because to major companies merging and acquiring to increase their product ranges. The present competitive climate encourages diagnostic innovation and improvement.
Educational activities and community participation projects are raising public awareness and aiding rabies diagnosis. Due to exposure concerns, patients seek quick medical help, increasing diagnostic demand.
Rabies Diagnostics Market Highlights:
Global Rabies Diagnostics Market Overview
The Rabies Diagnostics Market Size was valued at USD 2.11 Billion in 2023. The global rabies diagnostics industry is projected to grow from USD 2.26 Billion in 2024 to USD 3.56 Billion by 2032, exhibiting a CAGR of 5.21% during the forecast period (2024 - 2032).
Rabies spread through an animal bite or saliva with symptoms like fever, muscle spasms, excess salivation, headache, and mental instability.
The common rabies diagnostic methods include the Fluorescent Antibody Test (FAT), Direct Fluorescent Antibody (DFA) test, immunohistochemical tests, and amplification methods. The key market driving factor is the rise in awareness and concern for animal-related diseases. The growing awareness programs initiated by the government to fight against rabies and the growing necessity of immunization for humans and animals are enhancing the market. The surveillance strategies and development of rabies diagnostics kits contribute to the market's growth.
Major initiatives such as dog vaccinations, post-exposure prophylaxis (PEP) adoption, and the government's involvement in the laws regarding the diagnosis of rabies virus are aiding the market's growth. The rabies diagnostics market is accelerated by the rise in the adoption of advanced diagnostic solutions for rabies, the collaborations between research institutes and healthcare companies, novel rabies detection assays and kit development, and the initiatives organizations undertake to control the spread of rabies are factors propelling the market. The adoption of cutting-edge technologies for rabies diagnostic solutions is influencing more demand. On the other hand, the investments to support ongoing research activities and the invention of rabies diagnosis kits will increase the market's growth opportunities. The key player’s developments will boost the market.
Rabies Diagnostics Market Segment Insights
The global rabies diagnostics market has been segmented on the basis of method, technology, end-user, and region.
Rabies Diagnostics Method Insights
On the basis of method, the market has been classified as a fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histologic examination, and serology tests.
Rabies Diagnostics Technology Insights
Also, by technology, the market has been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR, and others.
Rabies Diagnostics End User Insights
Based on end-user, the market has been divided into hospitals, diagnostic centers, cancer palliative care clinics, and others. By end-user hospitals are likely to register the highest CAGR owing to the rising prevalence of rabies in emerging countries during the forecast period.
Rabies Diagnostics Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rabies diagnostics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European rabies diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Rabies Diagnostics Regional Market Summary
Asia-Pacific is likely to dominate the rabies diagnostics market during the forecast period owing to the improving healthcare infrastructure, rising investments in healthcare and expansions by market players in the region. Also, countries such as India and China are considering the fastest growing region due to a government focused toward adopting new technology and the best treatment option from a developed country. According to the World Health Organization, in 2010, the healthcare expenditure of India was 3.27% of GDP, whereas, in 2015 it has 3.89% of total GDP.
The Americas are likely to be the second-largest market in the global rabies diagnostics market owing to the rising strategic alliance by major players, increasing awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure. According to the American Pet Products Association's 2017-2018 National Pet Owners Survey, Number of animals in the American region is increasing, and there were around 60.2 million dogs, and 47.1pet cats were present in the Americas.
The European market is expected to hold a significant share in the rabies diagnostics market. The market growth in this region can be attributed to the government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development.
The market in the Middle East & Africa is expected to account for the smallest share of the global rabies diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Rabies Diagnostics Market Key Players
Some of the key players in the global Rabies Diagnostics Market are
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Aviva Systems Biology Corporation
- Creative Diagnostics
- Demeditec Diagnostics GmbH
- Abbexa Ltd.
- Norgen Biotek Corp.
- BioNote, Inc.
- Express Biotech International Inc.
- MyBioSource.com
- BioGen Technologies
Recent Development
In April 2022
Cadila Pharmaceuticals announced that it had developed the world's first novel three-dose vaccine against rabies. The three-dose vaccine, named 'ThRabis,' is a recombinant nano-particle-based G protein vaccine prepared using Virus-like Particle technology.
The company added that the three-dose schedule is spread over one week.
The new vaccine will prove to be a game-changer because all the other rabies vaccines require five injections over 28 days to eliminate the threatCadila, Pharmaceuticals said at the launch ceremony of the new vaccine.
Rabies Diagnostics Market Segmentation
Rabies Diagnostics Method Outlook
- Fluorescent Antibody Test (FAT)
- Immunohistochemical Test
- Amplification Methods
- Histologic Examination
- Serology Tests
Rabies Diagnostics Technology Outlook
- ELISA/Immunohistochemistry
- Chromatography Techniques
- PCR
- Other
Rabies Diagnostics End User Outlook
- Hospitals
- Diagnostic centers
- Cancer Palliative care clinics
- Others
Rabies Diagnostics Regional Outlook
- Americas
- North America
- US
- Canada
- Latin America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Intended Audience
- Rabies Diagnostics Manufacturers
- Rabies Diagnostics Distributors and Suppliers
- Healthcare Providers
- Research Institutes and Academic Centers
- Medical Devices Manufacturers
- Government Associations
- Market Research and Consulting
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
